Current Use of Asparaginase in Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
Pediatric Acute Lymphoblastic Leukemia (ALL) cure rates have improved exponentially over the past five decades with now over 90% of children achieving long-term survival. A direct contributor to this remarkable feat is the development and expanded understanding of combination chemotherapy. Asparagin...
Tallennettuna:
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Frontiers Media S.A.
2022-06-01
|
| Sarja: | Frontiers in Pediatrics |
| Aiheet: | |
| Linkit: | https://www.frontiersin.org/articles/10.3389/fped.2022.902117/full |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|